Literature DB >> 11039900

Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages.

U Holtrich1, G Wolf, J Yuan, J Bereiter-Hahn, T Karn, M Weiler, G Kauselmann, M Rehli, R Andreesen, M Kaufmann, D Kuhl, K Strebhardt.   

Abstract

Members of the polo subfamily of protein kinases play crucial roles in cell proliferation. To study the function of this family in more detail, we isolated the cDNA of human Fnk (FGF-inducible kinase) which codes for a serine/threonine kinase of 646 aa. Despite the homology to the proliferation-associated polo-like kinase (Plk), tissue distribution of Fnk transcripts and expression kinetics differed clearly. In contrast to Plk no correlation between cell proliferation and Fnk gene expression was found. Instead high levels of Fnk mRNA were detectable in blood cells undergoing adhesion. The transition of monocytes from peripheral blood to matrix bound macrophages was accompanied by increasing levels of Fnk with time in culture. Neither treatment of monocytes with inducers of differentiation nor withdrawal of serum did influence Fnk mRNA levels significantly, suggesting that cell attachment triggers the onset of Fnk gene transcription. The idea that Fnk is part of the signalling network controlling cellular adhesion was supported by the analysis of the cytoplasmic distribution of the Fnk protein and the influence of its overexpression on the cellular architecture. Fnk as fusion protein with GFP localized at the cellular membrane in COS cells. Dysregulated Fnk gene expression disrupted the cellular f-actin network and induced a spherical morphology. Furthermore, Fnk binds to the Ca2+/integrin-binding protein Cib in two-hybrid-analyses and co-immunoprecipitation in assays. Moreover, both proteins were shown to co-localize in mammalian cells. The homology of Cib with calmodulin and with calcineurin B suggests that Cib might be a regulatory subunit of polo-like kinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039900     DOI: 10.1038/sj.onc.1203845

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells.

Authors:  Meghna U Naik; Ngoc T Pham; Kristin Beebe; Wei Dai; Ulhas P Naik
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

Review 2.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.

Authors:  Wilko Weichert; Glen Kristiansen; Klaus-Jürgen Winzer; Mathias Schmidt; Volker Gekeler; Aurelia Noske; Berit-Maria Müller; Silvia Niesporek; Manfred Dietel; Carsten Denkert
Journal:  Virchows Arch       Date:  2005-03-23       Impact factor: 4.064

4.  Polo-like kinase 3 is required for entry into S phase.

Authors:  Wendy C Zimmerman; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

5.  Calcium- and integrin-binding protein 1 regulates microtubule organization and centrosome segregation through polo like kinase 3 during cell cycle progression.

Authors:  Meghna U Naik; Ulhas P Naik
Journal:  Int J Biochem Cell Biol       Date:  2010-10-15       Impact factor: 5.085

6.  Role of Plk2 (Snk) in mouse development and cell proliferation.

Authors:  Sheng Ma; Jean Charron; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 7.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.

Authors:  Pavel Bostik; Geraldine L Dodd; Francois Villinger; Ann E Mayne; Aftab A Ansari
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 9.  CIB1: a small protein with big ambitions.

Authors:  Tina M Leisner; Thomas C Freeman; Justin L Black; Leslie V Parise
Journal:  FASEB J       Date:  2016-04-26       Impact factor: 5.191

10.  Cytoskeletal architecture and cell motility remain unperturbed in mouse embryonic fibroblasts from Plk3 knockout mice.

Authors:  Daniel R Michel; Kyu-Shik Mun; Chia-Chi Ho; Peter J Stambrook
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.